台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    41.95
  • 漲跌
    ▲0.75
  • 漲幅
    +1.82%
  • 成交量
    66
  • 產業
    上市 生技醫療類股
  • 127人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-元大-楊梅 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0402/1803/0203/1203/2404/0604/1601/1602/0604/1830354045505560May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

元大-楊梅 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/14039.8000.0039.7003140.00%
2025/04/09037.7800.0036.1003330.00%
2025/03/28045.4500.0045.6003190.00%
2025/03/27046.5500.0045.9003190.00%
2025/03/24045.0500.0044.9003210.00%
2025/03/1400.000.147.0047.20-0.1339-0.03%
2025/03/0700.00049.7850.2003340.00%
2025/03/06049.5500.0050.9003310.00%
2025/03/05150.09050.1049.6013240.32%
2025/03/04054.3000.0053.7003020.00%
2025/02/27052.40153.9052.70-1286-0.33%
2025/02/2100.000.249.8449.90-0.2276-0.06%
2025/02/20048.75049.9549.450274-0.01%
2025/02/180.249.1200.0049.300.22740.06%
2025/02/17049.610.449.9849.95-0.4273-0.13%
2025/02/130.349.5100.0049.450.32710.12%
2025/02/1000.001.250.8951.60-1.2268-0.45%
2025/02/071.249.92150.0050.500.22630.08%
2025/02/06149.000.349.0450.900.82580.29%
2025/02/050.347.7500.0047.650.32480.10%
2025/02/0300.000.150.7050.70-0.1238-0.04%
2025/01/220.150.3000.0050.300.12350.04%
2025/01/200.249.770.150.9051.200.12320.04%
2025/01/170.249.6500.0049.800.22280.07%
2025/01/1600.000.150.0051.00-0.1226-0.02%
2025/01/150.149.1000.0049.300.12220.02%
2025/01/0200.00149.0049.00-1137-0.73%
2024/12/3000.000.149.3048.85-0.1137-0.07%
2024/12/0400.00045.7545.950101-0.02%
2024/12/03044.8000.0045.1001040.02%
2024/11/2500.000.244.3844.55-0.2108-0.18%
2024/11/220.243.6000.0044.000.21090.18%
2024/09/2700.000.242.4542.35-0.2298-0.07%
2024/09/1800.001.943.5043.90-1.9392-0.48%
2024/08/3000.00146.5546.55-1419-0.24%
2024/08/06037.7500.0038.9504170.00%
2024/07/19148.70249.3846.50-1384-0.26%
2024/07/18146.65147.0548.0003460.00%
2024/07/12145.2000.0044.9513290.30%
2024/07/1000.00145.2545.35-1329-0.30%
2024/07/04249.43149.4049.5512950.34%
2024/07/03150.30150.5050.4002840.00%
2024/07/023.150.97350.8750.400.12620.04%
2024/06/11145.7000.0045.7011570.63%
2024/06/0600.00044.8044.9001540.00%
2024/06/05044.5500.0044.9001530.00%
2024/06/04145.4000.0044.3011490.67%
2024/05/2800.00042.4042.5501410.00%
2024/05/27042.2000.0041.9501400.00%
2024/05/1500.00143.1043.20-1137-0.73%
2024/05/10142.75143.3543.4001550.00%
2024/04/230.142.7500.0042.800.11600.06%
2024/04/180.143.8000.0043.950.11580.03%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章